Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT 06519, USA.
Endocr Pract. 2013 Jan-Feb;19(1):e1-7. doi: 10.4158/EP12181.CR.
Granulomatosis with polyangiitis (GPA), also known as Wegener's granulomatosis, is an autoimmune disease characterized by inflammation of blood vessels most often seen in the upper respiratory tract, lungs, kidneys, and skin. Central nervous system (CNS) involvement of GPA is rare, particularly in the pituitary, and can be difficult to treat.
Case report.
We present a 30-year-old woman with pituitary and ocular GPA, whose unusually recalcitrant disease led to the development of pan-hypopituitarism and near-total vision loss. After failing multiple systemic immunosuppressants, she was ultimately treated with the novel immunomodulatory agent rituximab together with pulse corticosteroids, which achieved a gratifying response.
Pituitary and optic chiasm involvement is a rare complication of GPA. We believe this case illustrates the complexity of management of pituitary GPA and provides insight into the potential utility of the biologic agent rituximab in this disease.
肉芽肿性多血管炎(GPA),也称为韦格纳肉芽肿,是一种自身免疫性疾病,其特征为血管炎症,最常发生在上呼吸道、肺部、肾脏和皮肤。GPA 的中枢神经系统(CNS)受累很少见,特别是在垂体,且可能难以治疗。
病例报告。
我们报告了一例 30 岁女性的垂体和眼部 GPA,其疾病异常顽固,导致全垂体功能减退和几乎完全视力丧失。在多次全身免疫抑制剂治疗失败后,她最终接受了新型免疫调节药物利妥昔单抗联合脉冲皮质类固醇治疗,取得了令人满意的疗效。
垂体和视交叉受累是 GPA 的罕见并发症。我们认为该病例说明了垂体 GPA 管理的复杂性,并为生物制剂利妥昔单抗在该疾病中的潜在应用提供了启示。